Chylomicron remnants: hepatic receptors and metabolism
- PMID: 8520854
- DOI: 10.1097/00041433-199510000-00011
Chylomicron remnants: hepatic receptors and metabolism
Abstract
Recent studies support a sequential model for hepatic processing and catabolism of chylomicron remnants. Removal of chylomicron remnants by the liver involves interaction with several macromolecules on the cell surface, including the LDL receptor and heparan-sulfate-bound hepatic lipase and apolipoprotein E. Endocytosis of chylomicron remnants into hepatocytes is mediated by apolipoprotein E and normally occurs through the LDL receptor. Interaction of chylomicron remnants with the LDL receptor-related protein, or another endocytic receptor with similar properties, occurs slowly, requiring modification of surface-bound chylomicron remnants, and serves as a backup mechanism that is utilized primarily when LDL receptors are deficient or down-regulated.
Similar articles
-
Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.Proc Natl Acad Sci U S A. 1995 May 9;92(10):4611-5. doi: 10.1073/pnas.92.10.4611. Proc Natl Acad Sci U S A. 1995. PMID: 7753850 Free PMC article.
-
Receptor and non-receptor mediated uptake of chylomicron remnants by the liver.Atherosclerosis. 1998 Dec;141 Suppl 1:S1-7. doi: 10.1016/s0021-9150(98)00211-1. Atherosclerosis. 1998. PMID: 9888635
-
Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver.Hepatology. 1996 Aug;24(2):344-51. doi: 10.1053/jhep.1996.v24.pm0008690403. Hepatology. 1996. PMID: 8690403
-
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.J Lipid Res. 1999 Jan;40(1):1-16. J Lipid Res. 1999. PMID: 9869645 Review.
-
Receptor-mediated mechanisms of lipoprotein remnant catabolism.Prog Lipid Res. 1998 Dec;37(6):393-422. doi: 10.1016/s0163-7827(98)00017-4. Prog Lipid Res. 1998. PMID: 10209655 Review.
Cited by
-
Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase.Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15647-52. doi: 10.1073/pnas.95.26.15647. Proc Natl Acad Sci U S A. 1998. PMID: 9861024 Free PMC article.
-
Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.J Clin Invest. 1998 Apr 15;101(8):1726-36. doi: 10.1172/JCI2181. J Clin Invest. 1998. PMID: 9541504 Free PMC article.
-
Postprandial lipemia and cardiovascular disease.Curr Atheroscler Rep. 2003 Nov;5(6):437-44. doi: 10.1007/s11883-003-0033-y. Curr Atheroscler Rep. 2003. PMID: 14525676 Review.
-
In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.J Clin Invest. 1996 Nov 15;98(10):2259-67. doi: 10.1172/JCI119036. J Clin Invest. 1996. PMID: 8941642 Free PMC article.
-
Postprandial triglyceride metabolism in diabetes mellitus.Clin Cardiol. 1999 Jun;22(6 Suppl):II28-33. doi: 10.1002/clc.4960221406. Clin Cardiol. 1999. PMID: 10376194 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources